The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanayama, N.
Right arrow Articles by Ohmori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanayama, N.
Right arrow Articles by Ohmori, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITROPHENOLS
The Journal of Immunology, 2005, 174: 1438-1445.
Copyright © 2005 by The American Association of Immunologists

Analysis of Marginal Zone B Cell Development in the Mouse with Limited B Cell Diversity: Role of the Antigen Receptor Signals in the Recruitment of B Cells to the Marginal Zone1

Naoki Kanayama*, Marilia Cascalho{dagger} and Hitoshi Ohmori2,*

* Department of Bioscience and Biotechnology, Faculty of Engineering, Okayama University, Tsushima-Naka, Okayama, Japan; and {dagger} Department of Surgery and Immunology, Mayo Clinic, Rochester, MN 55905


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The quasimonoclonal (QM) mouse provides an intelligible model to analyze the B cell selection as the competition between two major 4-hydroxy-3-nitrophenylacetyl-specific B cell populations whose BCR are comprised of the knockin VH17.2.25 (VHT)-encoded H chain and the {lambda}1 or {lambda}2 L chain. In this study, we show the QM system is useful to examine how BCR signals guide a subset of B cells to the marginal zone (MZ). Compared with the control C57BL/6 mice, the QM mice had ~2.7-fold increased number of B cells exhibiting the MZ B cell phenotype and a larger MZ area in the spleen. Interestingly, VHT/{lambda}2 B cells significantly predominated over VHT/{lambda}1 B cells in MZ-(VHT/{lambda}1:VHT/{lambda}2 {approx} 3:7) and transitional 2-B cell subsets, while these two populations were comparable in immature, transitional 1, and mature counterparts. Thus, the biased use of {lambda}2 in the MZ B cells may be the result of selection in the periphery. The enlargement of MZ B cell compartment and the preferred recruitment of the VHT/{lambda}2 B cells were further augmented by doubling the VHT gene, but dampened by the dysfunction of Bruton’s tyrosine kinase, suggesting a positive role of BCR signaling in this selection. Comparison of Ag specificity between VHT/{lambda}1 and VHT/{lambda}2 IgM mAbs revealed a polyreactive nature of the VHT/{lambda}2 BCR, including the reactivity with ssDNA. Taken together, it is suggested that polyreactivity (including self-reactivity) of BCR is crucial in driving B cells to differentiate into the MZ phenotype.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Marginal zone (MZ)3 B cells belong to a subset of mature B cells that localizes in the vicinity of the marginal sinus surrounding lymphoid follicles in the spleen (1, 2). MZ B cells exhibit characteristic surface markers (IgMhighIgDlowCD21highCD23low/–) that are different from those of conventional follicular (FO) B cells (IgM+IgDhighCD21intermediate(int)CD23high), and show partially activated properties and very long life spans (3, 4, 5, 6). MZ B cells are considered to play a vital role in the first line of defense against blood-borne bacterial infection by rapidly responding to Ags, often in a T cell-independent (TI) fashion (7, 8, 9).

Signals mediated by the BCR may be critical in the commitment of B cells to MZ B cell compartment (reviewed in Refs. 2, 10 and 11). Although the origin of MZ B cells remains controversial, newly formed (NF) B cells are most likely the immediate precursors (12, 13, 14, 15), while an origin from FO B cells is also suggested (16, 17). Accumulating evidence indicates that MZ B cells may be positively selected by BCR signals that might be distinct from those required for generating FO B cells. For instance, IgH transgenic (Tg)-B cells expressing M167 or VH81X Id, either of which is related to autoreactivity, can be enriched into the MZ (13, 18). Stimulation with autologous Ags or endogenous microfloras might play a role in the positive selection of MZ B cells (2). In addition, gene knockouts of positive regulators for BCR signaling, including CD19, impaired the development of MZ B cells without markedly affecting the generation of FO B cells (10, 13, 14). In contrast, the dysfunction of Bruton’s tyrosine kinase (Btk) that is an essential component of the BCR signalosome led to defects in the development of FO B cells with the MZ B cell compartment being intact (12, 14). Although an optimal strength of BCR signals tuned by positive and negative regulators may be favorable for the generation of MZ B cells (11, 12, 13, 19), a model remains to be established that can accommodate contradictory data from knockout lines for BCR signaling.

If the development of MZ B cells can be assessed in Ig Tg mice whose B cell repertoire is restricted and expresses BCR with a defined Ag specificity, the selection process toward MZ B cells will be more profoundly understood in terms of the intensity of BCR signals. For this purpose, we analyzed the MZ B cell compartment in the quasimonoclonal (QM) mouse whose B cell repertoire is restricted (20). The QM mouse is a strain bearing the site-directed VH gene, in which one of the JH loci is replaced by the 17.2.25 VHDJH segment (VHT) encoding 4-hydroxy-3-nitrophenylacetyl (NP)-specific mAb and the other JH and both J{kappa}C{kappa} loci are disrupted. Thus, the VHT H chains are expressed on ~80% of peripheral B cells, about one-half of which use {lambda}1 as the L chain (VHT/{lambda}1) and the other half use {lambda}2 (VHT/{lambda}2) (21). Recently, we have reported that the QM mice provide a useful experimental system to analyze the B cell clonal selection and the recruitment of the selected cells to affinity maturation pathway as the result of the competition between two major B cell populations, VHT/{lambda}1 and VHT/{lambda}2 (21). QM mice may also be useful to examine the development of MZ B cells, because we found that the MZ B cells were dominated by VHT/{lambda}2 B cells, while there was no such bias in the VHT+ B cell population in the follicle or the bone marrow. In the present study, we investigated the role of BCR signaling in the development of MZ B cells by examining how this biased recruitment was brought about.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Mice

C57BL/6 and MRL/Mp lpr/lpr mice were purchased from Charles River Laboratories Japan. X-linked immunodeficient (Xid) (CBA/N) mice were purchased from Japan SLC. QM mice (VHT/JH–, J{kappa}C{kappa}–/J{kappa}C{kappa}–, {lambda}+/{lambda}+) have been previously established (20) and backcrossed onto C57BL/6 mice at least for nine generations (22). QM mice homozygous for the VHT gene (VHT/VHT, J{kappa}–/J{kappa}–, {lambda}+/{lambda}+) were generated (QM (VHT/VHT)). The heterozygous (VHT/JH–) mice were usually used, unless otherwise stated. The QM (VHT/VHT) mice were crossed with Xid mice to generate the QM mouse strain (QM Xid) carrying a point mutation in the exon 1 of btk (VHT/VHT, J{kappa}–/J{kappa}–, {lambda}+/{lambda}+, Xid/Y) (23). Genotypes were determined with PCR using specific primers to targeted loci and a mutant btk locus: AAGACACCTATATGCACTGG for VHT, CTCGTGCTTTACGGTATCGC for JH–, and ATCTGCCAGAACTGAAGCTTGAAGTCTGAG for germline JH as sense primers; CAACTATCCCTCCAGCCATAGGAT for antisense of JH-Cµ intron; CTCGTGCTTTACGGTATCGC and CTTTGATACGTGGGCTCTTCATAC for J{kappa}C{kappa}–; GTGGAAGATTGATGGCAGTGAACG and TGCCATGTAGTGGACAGCCAAC for germline C{kappa}; and AACATCACCTTTAAACTTCAAGAAGT and TCAGGAATTACTGTTTCAACACAGG for a mutant btk. Mice at 8–15 wk of age were used throughout present experiments. All mice were treated in accordance with the guidelines approved by the Committee of Laboratory Animal Care, Okayama University.

Flow cytometric analysis

Single cell suspensions were prepared from the spleen, lymph nodes (axillary, brachial, inguinal, and popliteal), and bone marrow. Cells were stained with anti-mouse Abs in PBS containing 0.2% BSA, 0.1% sodium azide, and, if necessary, 50 µg/ml normal rat IgG as a blocking reagent (Valeant Pharmaceuticals). FITC or CyChrome anti-B220 (RA3-6B2), FITC anti-CD21 (7G6), biotinylated anti-CD21, PE anti-CD23 (B3B4), PE anti-CD86 (GL1), PE anti-CD24 heat-stable Ag (HSA) (J11d), biotinylated anti-{lambda}1 L chain (R11-153), and biotinylated anti-{lambda}2 and -{lambda}3 L chain (2B6) were purchased from BD Pharmingen. As previously noted, B cells stained with anti-{lambda}2 and -{lambda}3 L chain mAb were occupied by {lambda}2+ B cells in QM mice (21). Biotinylated goat anti-mouse IgD and PE anti-mouse IgM were used for surface Ig staining of B cells (Southern Biotechnology Associates). B cells bearing VHT-encoded IgH were detected with biotinylated mAb to the Id of VHT, R2.438 (a gift from T. Imanishi-Kari, Tufts University, Boston, MA). Biotinylated Abs were visualized with FITC-, PE (Sigma-Aldrich)-, or CyChrome-labeled streptavidin (BD Pharmingen). Stained cells were analyzed with FACSCalibur and CellQuest software (BD Biosciences). To carry out four-color analysis, PerCP-Cy5.5 anti-IgM mAb (R6-60.2) (BD Pharmingen), FITC anti-CD1d mAb (1B1), and allophycocyanin-labeled streptavidin (eBioscience) were used for staining, and the stained cells were analyzed with FACS Aria and FACS DiVa software (BD Biosciences). Statistical analysis was performed using unpaired Student’s t test with two-tailed p values.

Immunohistochemical analysis

Spleens were removed, frozen in Tissue-Tek OCT compound (Miles), and subjected to immunofluorescent staining, as described previously (24). Cryosections (8–10 µm thick) were mounted onto slides, air dried for 20 min, fixed in ice-cold acetone/methanol (1:1) for 10 min, rehydrated in PBS, and preblocked for 30 min with PBS containing 1% BSA and 50 µg/ml normal rat IgG. Sections were stained with Cy3 goat anti-mouse IgM (Chemicon International), FITC MOMA-1 (Serotec), biotinylated anti-mouse IgD, anti-{lambda}1 L chain, and anti-{lambda}2 and -{lambda}3 L chain, followed by FITC-labeled streptavidin. The slides were finally mounted with low fluorescent glycerol and coverslip protection, and observed with a confocal laser-scanning microscope MRC-1024 (Bio-Rad).

Estimation of Ag specificity of mAbs

NP was conjugated to BSA by reacting the N-hydroxysuccinimide ester of 4-hydroxy-3-nitrophenylacetic acid (Tokyo Kasei Kogyo), as described previously (25). Trinitrophenyl (TNP)-BSA was prepared by the reaction of BSA with trinitrobenzene sulfonate (26, 27). Tyrosine residues of BSA were nitrated with peroxynitrite (Dojindo Laboratories) (28, 29, 30, 31). A total of 4 mg/ml BSA dissolved in a buffer containing 50 mM potassium phosphate (pH 7.4) and 25 mM potassium bicarbonate was incubated at 37°C for 1 min after adding peroxynitrite up to 1 mM. The addition and following incubation were repeated five times. Final products were dialyzed to PBS.

VHT/{lambda}1 and VHT/{lambda}2 IgM mAbs have been previously generated from QM B cells immunized with p-nitrophenylacetyl (pNP)-conjugated chicken {gamma}-globulin (21). Clones M175 (VHT/{lambda}1) and M46 (VHT/{lambda}2) were used as representatives. The absence of somatic mutations has been confirmed by sequencing VH and VL genes of these mAbs. Appropriately diluted mAbs were added to microplates coated with 10 µg/ml NP-BSA, TNP-BSA, tyrosine-nitrated BSA, Escherichia coli {beta}-galactosidase, bovine thyroglobulin, bovine cytochrome c (Sigma-Aldrich), or human insulin (Biomedical Technologies), and then incubated at 25°C for 1 h. After washing, bound mAbs were detected with peroxidase-conjugated goat IgG specific for mouse IgM (Southern Biotechnology Associates). The 2,2'-azino-bis-(3-ethylbenziazoline-6-sulfonate) plus H2O2 was used for assaying the bound second Abs that were labeled with HRP. Absorbance at 405 nm was measured by using a microplate reader MPR A4i (Tosoh).

Binding to ssDNA was measured, as reported previously (32). Calf thymus DNA (Sigma-Aldrich) was dissolved in SSC (0.15 M NaCl, 0.015 M sodium citrate, pH 8) and shared by passing through 26-gauge needle. DNA was heat denatured and chilled on ice immediately before use. Microplates were coated by 50 µg/ml ssDNA and blocked with 1% BSA. Bound Abs were detected, as described above. Data for specific binding to ssDNA were represented after subtraction of background binding to BSA on uncoated microplates. mAbs in use were bound to BSA in a negligible level.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Expansion of MZ B cells in QM mice

QM mice that predominantly express the knockin VHT-encoded H chains possess two major B cell populations, VHT/{lambda}1 and VHT/{lambda}2, each of which constitutes 45~50% of lymph node (LN) B cells (20, 21). We have reported that these two B cell populations showed comparable affinity for the hapten NP, but the VHT/{lambda}2 showed 50~100-fold higher affinity than the VHT/{lambda}1 for an NP analog, pNP (21). Thus, it is possible that autologous or environmental Ags differentially stimulate VHT/{lambda}1 and VHT/{lambda}2 B cells, and affect the subsequent commitment of these two B cell populations to different B cell compartments. If there is a bias in the proportion of these two B cells in some compartments, the QM mice will provide a useful system for analyzing how BCR specificity regulates the fate of B cells to differentiate into specialized subsets. This prompted us to assess B cell subsets in peripheral lymphoid tissues of QM mice.

By means of flow cytometry, splenic B cells of QM mice were separated into MZ and FO B cells in terms of the surface expression of CD21 and CD23 (3) (Fig. 1A). CD21highCD23low/– MZ and CD21intCD23high FO B cells in QM mice exhibited distinct surface phenotypes: large B220highIgMhighIgDlowCD21highCD23low/–HSAhighCD86high cells and small B220highIgMintIgDhighCD21intCD23highHSAlowCD86low cells, respectively (Fig. 1B). Interestingly, the proportion of CD21highCD23low/–B220+ MZ B cells in the QM mouse spleen was significantly higher (4.6-fold) than that in the control C57BL/6 mouse spleen (Fig. 1, A, top row, and C). Reciprocally, the proportion of CD21intCD23highB220+ FO B cells was decreased in QM mice. CD21highCD23low/– B cells were almost absent in the LN that did not possess the MZ structure (Fig. 1A, top row). Importantly, MZ B cells of QM mice were significantly increased not only in the proportion, but also in the absolute number (2.7-fold) compared with those of the control mice, while total B220+ cells and FO B cells were decreased in QM mice (Fig. 1C). When splenic B cells were separated in terms of CD21 and IgM levels, the increase of CD21highIgMhighB220+MZ-type B cells in QM mice was similarly confirmed (Fig. 1A, bottom row). NF B cells that were defined as CD21–CD23– or CD21–IgMhigh were unchanged in the proportion, but decreased in the cell number (Fig. 1, A and C).



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 1. Flow cytometric analysis of the spleen and LN cells derived from QM and the control C57BL/6 mice. A, The dot plot profiles gated on B220+ are representatives of at least four mice. The numbers in the panels represent the percentages of the gated cells: B220+CD21highCD23low/– (MZ B), B220+CD21intCD23high (FO B), and B220+CD21low/–CD23low/– (NF B) cells (top row); B220+CD21highIgMhigh (MZ B), B220+CD21intIgM+ (FO B), and B220+CD21low/–IgMhigh (NF B) cells (bottom row). B, Surface phenotypes of splenic B cell subsets. Bold and thin lines in histogram plots indicate MZ B cells gated on CD21highCD23low/– and FO B cells gated on CD21intCD23high, respectively. C, The bar charts summarize the relative and absolute numbers of MZ B, FO B, and NF B cells in the spleen. Individual fractions defined in the top row of A were used for calculations. Data show the mean and SD. The difference between QM and the control mice was examined for statistical significance that is indicated as asterisks: *, p < 0.05; **, p < 0.01; ***, p < 0.001.

 
To examine the anatomical distribution of the expanded B cells with the MZ B cell phenotype in the spleen, histochemical analysis of frozen section was performed. Both in QM and C57BL/6 mice, the MZ could be observed as the outer layer of the B cell-rich area that is separated from the follicle by a layer of MOMA-1+ MZ metalophilic macrophages (Fig. 2). The MZ area of QM mice was larger than that of the control mice (Fig. 2, A and B). Additionally, cells in the enlarged MZ layer were stained as IgM+IgD–, while those in the follicle as IgM+IgD+ (Fig. 2D), indicating that the expanded MZ B cells, which were characterized as IgMhighIgDlow with flow cytometric analysis (Fig. 1B), were localized in the MZ.



View larger version (104K):
[in this window]
[in a new window]
  		FIGURE 2. Anatomic enlargement of the MZ in QM mice. Frozen sections derived from the control C57BL/6 (A and C) and QM mice (B and D) were stained with MOMA-1 (green) and anti-IgM (red) (A and B), or with anti-IgD (green) and anti-IgM (red) (C and D). Data are representatives of three mice.

 
Predominance of VHT/{lambda}2 B cells in the MZ

We have previously shown that each VHT/{lambda}1 and VHT/{lambda}2 B cell population has a comparable size in the LN of QM mice (21). As MZ B cells of QM mice were increased in comparison with those of the control mice, we examined whether or not the ratio of VHT/{lambda}1 to VHT/{lambda}2 was maintained in this specialized microenvironment. CD21highCD23low/– MZ B cells expressed the VHT Id with higher frequency than CD21intCD23high FO B cells (MZ B, 88.0 ± 1.7%; FO B, 73.0 ± 6.6%; p < 0.01) (Fig. 3). Very interestingly, ~70% of the MZ B cells were found to bear {lambda}2-chains, while {lambda}1-chains were expressed on only 10~20% of the MZ B cells ({lambda}1, 17.9 ± 5.7%; {lambda}2, 70.0 ± 2.8%; p < 0.001) (Fig. 3). A similar repertoire shift was observed when the splenic MZ B cells were assessed as CD21highIgMhigh B cells (data not shown). In contrast, the biased usage of {lambda}2-chains was not observed in the FO B cells of the spleen ({lambda}1, 42.3 ± 5.7%; {lambda}2, 43.4 ± 4.1%) (Fig. 3) as well as in the recirculating equivalents in the LN (21). When B cells prepared from the spleen were stimulated with LPS or anti-CD40 mAb, {lambda}2+ B cells responded more rapidly than {lambda}1+ B cells (data not shown), thus suggesting that the {lambda}2+ B cell pool more abundantly contains the MZ B cells that have been reported to be more responsive to LPS or anti-CD40 than the FO counterparts (3, 4). Collectively, these results show that the VHT/{lambda}2 B cells were preferentially recruited to the MZ in QM mice. Thus, to investigate why the VHT/{lambda}2 B cells were committed to the MZ more efficiently in comparison with the VHT/{lambda}1 counterparts will lead to the elucidation of the role of BCR in MZ B cell development.



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 3. Repertoire analysis of splenic B cell subsets in QM mice. The usage of VHT Id or {lambda}-chains was examined for B cells gated on CD21highCD23low (MZ B, left panels) or CD21intCD23high (FO B, right panels). Data are representatives of six mice.

 
The bias to VHT/{lambda}2 in the MZ is determined in the periphery

NF B cells have been reported to be precursor candidates of MZ B cells (12, 13). To examine whether the preferential use of {lambda}2-chains in the MZ B cells was due to the biased generation of {lambda}2-bearing B cells in the bone marrow or to the selection done in the periphery, we examined the {lambda}-chain usage of immature B cells in the bone marrow and transitional B cells in the spleen. In contrast to the bias to {lambda}2-chains in the MZ B cells, immature B cells expressed {lambda}1-chains with rather higher frequency than {lambda}2-chains (Fig. 4). This {lambda}1 bias in the immature stage also has been reported in wild-type or several other IgH Tg mice (33, 34). Transitional B cells in the spleen were separated by expression levels of CD23, CD21, and IgM (12). Similarly to immature B cells in the bone marrow, the {lambda}2 bias was not found in CD23–CD21lowIgMhigh transitional 1 (T1) B cells (Fig. 5), and in CD23+CD21intIgMint mature follicular B cells (Figs. 3 and 5). Interestingly, {lambda}2+ B cells significantly accumulated in CD23+CD21highIgMhigh transitional 2 (T2) B cell compartment (Fig. 5). T2 cells can be subdivided by CD1d expression (35), and CD1d+ T2 cells have been presumed as precursors of MZ B cells (MZP) (11, 19). CD23+IgMhighCD1d+ MZP cells were also predominantly occupied by {lambda}2+ B cells (Fig. 5). Therefore, these results suggest that the biased {lambda}-chain usage of the MZ B cells was determined in the periphery, probably at the T2 stage in the spleen.



View larger version (30K):
[in this window]
[in a new window]
  		FIGURE 4. The {lambda}-chain usage of newly formed immature B cells in the bone marrow of QM mouse. A, Immature B cells gated on B220lowIgM+ were examined. B, Data from six mice are summarized in the bar chart.

 


View larger version (44K):
[in this window]
[in a new window]
  		FIGURE 5. The {lambda}-chain usage of peripheral immature B cell subsets in the spleen of QM mouse. Splenic B cells gated on CD23+ or CD23– were separated to CD23–CD21–IgMhigh (T1), CD23+CD21highIgMhigh (T2), CD23+CD1highIgMhigh (MZP), CD23+CD21intIgMint mature follicular (MF), CD23–CD21highIgMhigh (MZ) B cells. The usage of {lambda}-chains was examined for each B cell subset. The numbers in the panels indicate the mean and SD of five (T1, T2, MF, and MZ) or three (MZP) mice. The usage of {lambda}-chains in each subset was examined for statistical significance that is indicated as asterisks: *, p < 0.05; **, p < 0.01; ***, p < 0.001.

 
BCR signals are responsible for the repertoire bias of MZ B cells

To examine how the intensity of BCR signals regulates the differentiation to MZ B cells, we analyzed MZ B cell development in QM mice whose BCR signals were either strengthened or weakened by genetic manipulations. It has been shown that B cell development is affected by the expression level of BCR, which varies with the hemizygous or homozygous allelic status of Ig transgenes (36, 37, 38, 39, 40, 41). In the QM mice that were homozygous for the VHT gene (QM (VHT/VHT)), BCR signals are considered to be augmented owing to an increased density of BCR. In contrast, the QM mice bearing the Xid mutation (QM Xid) were generated by crossing QM (VHT/VHT) mice with CBA/N mice to observe MZ B cell development under conditions in which BCR signals were attenuated by the defect in Btk.

Splenic B cells of QM (VHT/VHT) mice were compared with those of the original QM (VHT/JH–) mice by flow cytometry (Fig. 6). The MZ B cells of QM (VHT/VHT) mice were significantly increased both in the proportion (1.3-fold) and cell number (1.8-fold), while the number of FO B cells was not meaningfully changed (Fig. 6, A and B). Interestingly, the {lambda}2/{lambda}1 ratio of MZ B cells was found to be further increased in QM (VHT/VHT) (from 4.3 to 6.9) (Fig. 6C). Next, splenic B cells of QM Xid mice were compared with those of the control littermate QM (VHT/VHT) mice (Fig. 7). The absolute numbers of total splenic B220+ and FO B cells in QM Xid mice were markedly decreased (4.3- and 3.4-fold, respectively) compared with those in the control littermates (Fig. 7B), consistent with the previous report describing an impaired B cell development in Btk-deficient mice (42). Notably, the MZ B cells of QM Xid mice were reduced by 0.53 and 0.14 times in the proportion and the absolute number, respectively (Fig. 7, A and B). The proportion of MZ B cells appeared to be still higher in QM Xid mice than wild-type C57BL/6 mice (C57BL/6, 7.7 ± 0.5%; QM Xid, 26.9 ± 8.3%; p < 0.01). However, the number of MZ B cells was severely reduced in QM Xid mice (C57BL/6, 2.1 ± 0.4 x 106; QM Xid, 8.7 ± 3.6 x 105; p < 0.01) (Figs. 1 and 7). More importantly, the bias toward the {lambda}2-chain in MZ B cells was significantly canceled in QM Xid mice (Fig. 7C). Taken together, these results suggest that signals delivered by the VHT/{lambda}2 BCR have a positive role in the selection and/or survival of the VHT/{lambda}2 B cells to be committed to MZ B cells.



View larger version (31K):
[in this window]
[in a new window]
  		FIGURE 6. Comparison between splenic B cell subsets of the original (VHT/JH–) and homozygous (VHT/VHT) QM mice. A, Flow cytometric analysis of splenic B cells. The dot plot profiles gated on B220+ are representatives of at least four mice. B, The bar charts summarize the relative and absolute cell numbers calculated from dot plot data represented in A. C, The usage of VHT Id or {lambda}-chains in splenic B cell subsets was examined for B cells gated on CD21highCD23low or CD21intCD23high as shown in Fig. 3. The {lambda}2/{lambda}1 ratio was estimated from the percentages of {lambda}-chains in each individual mouse. Data represent the mean and SD. The difference between heterozygous and homozygous mice was examined for statistical significance that is indicated as asterisk: *, p < 0.05.

 


View larger version (31K):
[in this window]
[in a new window]
  		FIGURE 7. The expansion and repertoire bias of MZ B cells depend on Btk tyrosine kinase function. A, Flow cytometric analysis of splenic B cells of QM Xid mice. Male QM Xid mice were analyzed. Littermate male QM mice were used as a control. The dot plot profiles gated on B220+ are representatives of at least three mice. B, The bar charts summarize the relative and absolute cell numbers calculated from dot plot data represented in A. C, The usage of VHT Id or {lambda}-chains in splenic B cell subsets was examined for B cells gated on CD21highCD23low or CD21intCD23high as shown in Fig. 3. The {lambda}2/{lambda}1 ratio was estimated from the percentages of {lambda}-chains in each individual mouse. Data represent the mean and SD. The difference between Xid and the control mice was examined for statistical significance that is indicated as asterisk: *, p < 0.05; **, p < 0.01.

 
B cells with an autoreactivity are enriched in MZ B cell compartment

To address the possibility as to whether the difference between VHT/{lambda}1 and VHT/{lambda}2 BCRs in Ag specificity including autoreactivity is involved in determining the recruitment of the latter B cells to the MZ, the specificities of the corresponding IgM mAbs toward various haptens and natural compounds were examined. VHT/{lambda}1 and VHT/{lambda}2 IgM mAbs showed comparable affinity to the NP hapten, as reported previously (Fig. 8) (21). In contrast, the VHT/{lambda}2 IgM mAb was more efficiently bound to other nitrophenyl moieties, including TNP and 3-nitrotyrosine, which has been known as an inflammation-associating marker (43, 44), than the VHT/{lambda}1 IgM mAb. More importantly, the VHT/{lambda}2 mAb reacted with a self Ag, ssDNA, but the VHT/{lambda}1 mAb did not. In addition, only the VHT/{lambda}2 mAb was polyreactive to several protein Ags, {beta}-galactosidase, insulin, thyroglobulin, and cytochrome c. Neither mAb showed detectable reactivity to dsDNA or phosphorylcholine (data not shown). Thus, it is suggested that a polyreactivity of the VHT/{lambda}2 BCR, including the reactivity to ssDNA, is one of the factors directing the recruitment of the VHT/{lambda}2 B cells to the MZ B cell compartment.



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 8. Ag specificities of VHT/{lambda}1 and VHT/{lambda}2 IgM mAbs. The Ag specificity was assessed by measuring the binding of serially diluted mAbs to microplates coated with NP-BSA (NP), TNP-BSA (TNP), tyrosine-nitrated BSA (3-nitrotyrosine), ssDNA, {beta}-galactosidase, insulin, thyroglobulin, or cytochrome c. VHT/{lambda}1 (•) and VHT/{lambda}2 ({circ}) IgM mAbs. As the controls of binding toward ssDNA, sera collected from C57BL/6 mice (n = 4) ({triangleup}) and MRL/Mp lpr/lpr mice (n = 5) ({blacktriangleup}) were used with 1/500-fold dilution. Data are presented as the mean of triplicate assays. Bar indicates the SD.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In QM mice whose ~80% of B cells express VHT/{lambda}1 or VHT/{lambda}2 BCR, we show that MZ and T2 B cells were predominantly occupied by the VHT/{lambda}2 B cells, whereas immature, T1, and FO B cell compartments were comparably populated by VHT/{lambda}1 and VHT/{lambda}2 B cells. The present results suggest that this bias is formed by the selection of VHT/{lambda}2 B cells at the T2 B cell stage due to the fact that the VHT/{lambda}2 BCR, but not VHT/{lambda}1 BCR, showed a polyreactivity including an autoreactivity to a self Ag ssDNA. Although the QM system may be nonphysiological and have limitations in analyzing MZ B cell development due to its limited B cell diversity, this characteristic feature, in contrast, may enable us to analyze the B cell differentiation as the competition/selection between the two major B cell populations. As reported previously, we showed that QM mice were advantageous in analyzing the selection and affinity maturation of B cells during an Ab response (21).

Analysis of the VHT/{lambda}2 bias of the MZ B cells in QM mice suggests that the Ag specificity of the VHT/{lambda}2 BCR has a critical role in the positive selection of the MZ B cells. The comparison between Ag specificities of VHT/{lambda}1 and VHT/{lambda}2 BCRs revealed that these two receptors showed similar reactivity to NP, but the latter bound more strongly to ssDNA, nitrophenyl haptens including 3-nitrotyrosine (Fig. 8) and pNP (21), and several protein Ags, suggesting a polyreactive nature of the VHT/{lambda}2 BCR. In addition, 3-nitrotyrosines on autologous proteins have been detected in inflammation sites (43). Thus, the polyreactivity, which potentially involves an autoreactivity, of VHT/{lambda}2 BCR may be responsible for the population bias of MZ B cells. These findings are consistent with the previous reports that weak reactivity with self Ags may be responsible for the differentiation to MZ B cells (13, 18). For instance, it has been reported that IgH Tg-B cells expressing the phosphorylcholine-binding Id M167 or the Id VH81X that reacts with unidentified self Ags, but not Tg B cells specific for xenogeneic hen egg lysozyme, were enriched into the MZ (13). Similarly, an increase of MZ B cells has been observed in the Tg mouse line that coexpresses a human natural Ab against human Fc{gamma} and a soluble human IgG (45), suggesting that soluble self Ags can be involved in the positive selection of MZ B cells.

The VHT/{lambda}2 B cells in the MZ are considered to be immunocompetent, because VHT/{lambda}2 B cells more readily responded to in vitro stimulation by LPS or anti-CD40 than the VHT/{lambda}1 counterparts (our unpublished data). The robust activation of B cells has been reported to occur by immunizing QM mice with a T cell-independent (TI)-Ag NP-Ficoll, indicating that the MZ B cells of QM mice can participate in TI Ag response (46). The MZ B cells bearing M167- or VH81X-autoreactive BCR have been previously shown to respond to TI Ags in vitro and in vivo (8, 13). In contrast, in 3H9 anti-DNA IgH knockin mice, anti-DNA B cells have been shown to escape deletion by coexpressing {lambda} and {kappa} L chains, and preferentially colonize in the MZ (47), suggesting that the MZ is a site in which autoreactive B cells are sequestered and rendered nontoxic. The VHT/{lambda}2 B cells were distributed not only in the MZ, but also in the splenic follicle and the LN (Figs. 1 and 3), and the recirculating VHT/{lambda}2 B cells have been shown to participate in T cell-dependent response to pNP-CGG (21). Therefore, the QM system indicates that an immunocompetent B cell clone bearing an autoreactive BCR is preferentially recruited into the MZ, but not necessarily excluded from the follicle.

The intensity of BCR signals may be critical for determining the fate of B cells to be recruited into MZ B cells. The preferred recruitment of VHT/{lambda}2 B cells was further augmented by rendering the VHT gene homozygous, but dampened by the impairment of Btk, suggesting a positive role of BCR signaling in this selection (Figs. 6 and 7). Likewise, the gene dose-dependent increase of MZ B cells has been reported in anti-RBC or anti-p-azophenylarsonate IgH Tg mouse line (41, 48). Thus, when the VHT gene was made homozygous, it is possible that the intensity of the augmented signals delivered by the homozygous BCR was within the optimal range for the development of MZ B cells, but did not exceed a threshold level required for negative selection. In contrast, augmented BCR signals in Aiolos knockout mice have been shown to lead to the absence of MZ B cells, suggesting that strong BCR signals favor the formation of FO over MZ B cells (19). In the QM system, Ag specificity might be more effective on BCR signals required for MZ B cell development than manipulations of BCR signaling examined in the present study, because the manipulations specifically affected the recruitment of VHT/{lambda}2 B cells to the MZ (Figs. 6 and 7).

In CBA/N mice with a Xid phenotype, there was a marked decrease in the number of FO B cells, while the number of MZ B cells was affected to a lesser extent (12, 14, 19). Thus, the proportion of MZ B cells apparently increased in these mice. In QM mice, however, the recruitment of VHT/{lambda}2 B cells to the MZ was found to depend on Btk profoundly, because introduction of Xid mutation led to the significant decrease of the MZ B cells and the compromise of the B cell repertoire (Fig. 7). The enrichment of IgH Tg B cells with 81X or M167 Id into the MZ also has been reported to require functional Btk (13). Recently, it has been shown that BCR signals via Btk activate integrin {alpha}4{beta}1-mediated adhesion of B cells to VCAM-1 (49), which may be involved in the B cell recruitment to the MZ (50). The observations in the QM mouse system in which major B cells are clonally defined in their Ag specificity suggest that Btk has an essential role in determining optimal intensity of BCR signals for B cell recruitment to the MZ.

In QM mice, MZ B cells were significantly increased in the absolute number (Fig. 1). Is the increase the result from accumulation of newly generated B cells from the bone marrow, or proliferation of a small subset of bone marrow- or fetal-derived cells? It has been proposed that the suppressed generation and diversification of B cells may lead to the expansion of long-lived B cell, including B-1 and MZ B cells, which contribute to maintain the production of natural Abs in a homeostatic manner (2, 5, 6). In addition, mice lacking serum IgM have been reported to show a MZ expansion, which was reversed by the administration of polyclonal IgM, but not of a mAb (51). However, although the B cell diversity in the spleen and LN of QM mice is contracted to two major populations (Fig. 3) (21), a variety of non-VHT-encoded Abs is produced from small populations of B cells whose VHT genes have been secondarily replaced with endogenous VH segments (52), and the MZ expansion in QM mice was not affected by adoptive transfer of the control C57BL/6 mouse sera that contained greater variety of Abs (our unpublished data). In the monoclonal BT mice whose B cells express only VHT and {lambda}1-chains (53), serum Ab level was severely reduced, but the number of MZ B cells was normal (our unpublished data). Furthermore, the bias was found in the T2 B cell stage (Fig. 5), suggesting a bone marrow origin of the VHT/{lambda}2 MZ B cells. Therefore, although the homeostatic mechanism cannot be excluded, the continuous supply of a large number of VHT/{lambda}2 B cells from the bone marrow in combination with the positive selection in the periphery may result in the extraordinary accumulation of the B cells in the MZ.

The results shown in Fig. 5 indicate that the repertoire bias observed in the MZ also occurred at the T2 and MZP stages in QM mice. MZP cells, a subpopulation of T2 cells, have been presumed as immediate precursors of MZ B cells, because MZP cells disappeared in parallel with MZ B cells in Aiolos- or Notch2-deficient mice (19, 54, 55). The relationship between BCR and Notch signals required for the selection of MZP cells is still unclear. The present results suggest that BCR signals probably given by Ag stimuli have a crucial role in the repertoire selection of precursor B cells for MZ B cells at the T2 stage. But, this should be further examined in other mosue systems.

Although there is the biased distribution of VHT/{lambda}2 B cells to the MZ, this population is present both in the MZ and follicle (Fig. 3). In the Xid background, both MZ and FO B cells expressing the VHT/{lambda}2 BCR were markedly reduced, while FO B cells expressing the VHT/{lambda}1 BCR were affected to a lesser extent (Fig. 7), implying that these two VHT/{lambda}2 B cell populations belonging to different compartments are maintained in a parallel manner. Recent reports have shown that VCAM-1+ and/or ICAM-1+ stromal cells and MZ macrophages have a critical role in the retention of B cells in the MZ B cell niche (50, 56). Because this niche is limited in the capacity to retain MZ B cells, an excess of VHT/{lambda}2 B cells may reside in the follicle and acquire FO B cell phenotypes. Another possibility is that a part of FO B cells can be precursors of MZ B cells (16, 17). By analyzing the molecular basis controlling the recruitment of VHT/{lambda}2 B cells into these two microenvironments, the QM system will give a clue to gain insight into the development mechanism of MZ B cells.


   Acknowledgments
 
We thank Dr. T. Imanishi-Kari (Tufts University) for generously providing the anti-Id mAb, R2.438. Confocal and sequence analyses were conducted at Venture Business Laboratory in Graduate School of Okayama University and at Center of Instrumental Analysis in Okayama University, respectively.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by grants-in-aid from Ministry of Education, Science, Sports, and Culture of Japan to H.O. (13037024 and 12450334) and N.K. (12750704). M.C. was supported by a grant from The National Institutes of Health (AI 48602). Back

2 Address correspondence and reprint requests to Dr. Hitoshi Ohmori, Department of Bioscience and Biotechnology, Faculty of Engineering, Okayama University, 3-1-1, Tsushima-Naka, Okayama 700-8530, Japan. E-mail address: hit2224{at}cc.okayama-u.ac.jp Back

3 Abbreviations used in this paper: MZ, marginal zone; Btk, Bruton’s tyrosine kinase; FO, follicular; HSA, heat-stable Ag; int, intermediate; LN, lymph node; MZP, MZ precursor; NF, newly formed; NP, 4-hydroxy-3-nitrophenylacetyl; pNP, p-nitrophenylacetyl; QM, quasimonoclonal; T1, transitional 1; T2, transitional 2; Tg, transgenic; TI, T cell independent; TNP, trinitrophenyl; Xid, X-linked immunodeficient. Back

Received for publication May 3, 2004. Accepted for publication November 24, 2004.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kraal, G.. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31.[Medline]
  2. Martin, F., J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323.[Medline]
  3. Oliver, A. M., F. Martin, G. L. Gartland, R. H. Carter, J. F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366.[Medline]
  4. Oliver, A. M., F. Martin, J. F. Kearney. 1999. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:7198.[Abstract/Free Full Text]
  5. Carvalho, T. L., T. Mota-Santos, A. Cumano, J. Demengeot, P. Vieira. 2001. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7–/– mice. J. Exp. Med. 194:1141.[Abstract/Free Full Text]
  6. Hao, Z., K. Rajewsky. 2001. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194:1151.[Abstract/Free Full Text]
  7. Guinamard, R., M. Okigaki, J. Schlessinger, J. V. Ravetch. 2000. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:31.[Medline]
  8. Martin, F., A. M. Oliver, J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14:617.[Medline]
  9. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:443.[Medline]
  10. Niiro, H., E. A. Clark. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2:945.[Medline]
  11. Cariappa, A., S. Pillai. 2002. Antigen-dependent B-cell development. Curr. Opin. Immunol. 14:241.[Medline]
  12. Loder, F., B. Mutschler, R. J. Ray, C. J. Paige, P. Sideras, R. Torres, M. C. Lamers, R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75.[Abstract/Free Full Text]
  13. Martin, F., J. F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12:39.[Medline]
  14. Makowska, A., N. N. Faizunnessa, P. Anderson, T. Midtvedt, S. Cardell. 1999. CD1high B cells: a population of mixed origin. Eur. J. Immunol. 29:3285.[Medline]
  15. Dammers, P. M., A. Visser, E. R. Popa, P. Nieuwenhuis, F. G. Kroese. 2000. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J. Immunol. 165:6156.[Abstract/Free Full Text]
  16. Dammers, P. M., N. K. de Boer, G. J. Deenen, P. Nieuwenhuis, F. G. Kroese. 1999. The origin of marginal zone B cells in the rat. Eur. J. Immunol. 29:1522.[Medline]
  17. Vinuesa, C. G., D. M. Sze, M. C. Cook, K. M. Toellner, G. G. Klaus, J. Ball, I. C. MacLennan. 2003. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens. Eur. J. Immunol. 33:297.[Medline]
  18. Chen, X., F. Martin, K. A. Forbush, R. M. Perlmutter, J. F. Kearney. 1997. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int. Immunol. 9:27.[Abstract/Free Full Text]
  19. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603.[Medline]
  20. Cascalho, M., A. Ma, S. Lee, L. Masat, M. Wabl. 1996. A quasi-monoclonal mouse. Science 272:1649.[Abstract]
  21. Kanayama, N., T. Kimoto, K. Todo, Y. Nishikawa, M. Hikida, M. Magari, M. Cascalho, H. Ohmori. 2002. B cell selection and affinity maturation during an antibody response in the mouse with limited B cell diversity. J. Immunol. 169:6865.[Abstract/Free Full Text]
  22. Erickson, L. D., B. G. Durell, L. A. Vogel, B. P. O’Connor, M. Cascalho, T. Yasui, H. Kikutani, R. J. Noelle. 2002. Short-circuiting long-lived humoral immunity by the heightened engagement of CD40. J. Clin. Invest. 109:613.[Medline]
  23. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, et al 1993. Mutation of unique region of Bruton’s tyrosine kinase in immunodeficient XID mice. Science 261:358.[Abstract/Free Full Text]
  24. Hikida, M., M. Mori, T. Takai, K. Tomochika, K. Hamatani, H. Ohmori. 1996. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 274:2092.[Abstract/Free Full Text]
  25. Magari, M., T. Sawatari, Y. Kawano, M. Cascalho, M. Wabl, N. Kanayama, M. Hikida, H. Ohmori. 2002. Contribution of light chain rearrangement in peripheral B cells to the generation of high-affinity antibodies. Eur. J. Immunol. 32:957.[Medline]
  26. Rittenberg, M. B., A. A. Amkraut. 1966. Immunogenicity of trinitrophenyl-hemocyanin: production of primary and secondary anti-hapten precipitins. J. Immunol. 97:421.[Abstract/Free Full Text]
  27. Ohmori, H., M. Hikida, T. Takai. 1990. Prostaglandin E2 as a selective stimulator of antigen-specific IgE response in murine lymphocytes. Eur. J. Immunol. 20:2499.[Medline]
  28. Koppenol, W. H., J. J. Moreno, W. A. Pryor, H. Ischiropoulos, J. S. Beckman. 1992. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5:834.[Medline]
  29. Hogg, N., V. M. Darley-Usmar, M. T. Wilson, S. Moncada. 1992. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281:419.
  30. Crow, J. P., H. Ischiropoulos. 1996. Detection and quantitation of nitrotyrosine residues in proteins: in vivo marker of peroxynitrite. Methods Enzymol. 269:185.[Medline]
  31. Berlett, B. S., B. Friguet, M. B. Yim, P. B. Chock, E. R. Stadtman. 1996. Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction. Proc. Natl. Acad. Sci. USA 93:1776.[Abstract/Free Full Text]
  32. Gilkeson, G. S., A. M. Pippen, D. S. Pisetsky. 1995. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95:1398.
  33. Sanchez, P., A. M. Drapier, M. Cohen-Tannoudji, E. Colucci, C. Babinet, P. A. Cazenave. 1994. Compartmentalization of {lambda} subtype expression in the B cell repertoire of mice with a disrupted or normal C{kappa} gene segment. Int. Immunol. 6:711.[Abstract/Free Full Text]
  34. Hachemi-Rachedi, S., A. Cumano, A. M. Drapier, P. A. Cazenave, P. Sanchez. 1997. Does positive selection determine the B cell repertoire?. Eur. J. Immunol. 27:1069.[Medline]
  35. Amano, M., N. Baumgarth, M. D. Dick, L. Brossay, M. Kronenberg, L. A. Herzenberg, S. Strober. 1998. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: {beta}2-microglobulin-dependent and independent forms. J. Immunol. 161:1710.[Abstract/Free Full Text]
  36. Lam, K. P., K. Rajewsky. 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190:471.[Abstract/Free Full Text]
  37. Watanabe, N., S. Nisitani, K. Ikuta, M. Suzuki, T. Chiba, T. Honjo. 1999. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J. Exp. Med. 190:461.[Abstract/Free Full Text]
  38. Kouskoff, V., G. Lacaud, K. Pape, M. Retter, D. Nemazee. 2000. B cell receptor expression level determines the fate of developing B lymphocytes: receptor editing versus selection. Proc. Natl. Acad. Sci. USA 97:7435.[Abstract/Free Full Text]
  39. Braun, U., K. Rajewsky, R. Pelanda. 2000. Different sensitivity to receptor editing of B cells from mice hemizygous or homozygous for targeted Ig transgenes. Proc. Natl. Acad. Sci. USA 97:7429.[Abstract/Free Full Text]
  40. Hachemi-Rachedi, S., A. M. Drapier, P. A. Cazenave, P. Sanchez. 2000. Affiliation to mature B cell repertoire and positive selection can be separated in two distinct processes. Int. Immunol. 12:385.[Abstract/Free Full Text]
  41. Sanchez, P., A. M. Crain-Denoyelle, P. Daras, M. C. Gendron, C. Kanellopoulos-Langevin. 2000. The level of expression of µ heavy chain modifies the composition of peripheral B cell subpopulations. Int. Immunol. 12:1459.[Abstract/Free Full Text]
  42. Khan, W. N., F. W. Alt, R. M. Gerstein, B. A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A. B. Kantor, L. A. Herzenberg, et al 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3:283.[Medline]
  43. Uesugi, M., K. Yoshida, H. E. Jasin. 2000. Inflammatory properties of IgG modified by oxygen radicals and peroxynitrite. J. Immunol. 165:6532.[Abstract/Free Full Text]
  44. Ohmori, H., N. Kanayama. 2003. Mechanisms leading to autoantibody production: link between inflammation and autoimmunity. Curr. Drug Targets Inflamm. Allergy 2:232.[Medline]
  45. Julien, S., P. Soulas, J. C. Garaud, T. Martin, J. L. Pasquali. 2002. B cell positive selection by soluble self-antigen. J. Immunol. 169:4198.[Abstract/Free Full Text]
  46. Sze, D. M., K. M. Toellner, C. Garcia de Vinuesa, D. R. Taylor, I. C. MacLennan. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813.[Abstract/Free Full Text]
  47. Li, Y., H. Li, M. Weigert. 2002. Autoreactive B cells in the marginal zone that express dual receptors. J. Exp. Med. 195:181.[Abstract/Free Full Text]
  48. Heltemes, L. M., T. Manser. 2002. Level of B cell antigen receptor surface expression influences both positive and negative selection of B cells during primary development. J. Immunol. 169:1283.[Abstract/Free Full Text]
  49. Spaargaren, M., E. A. Beuling, M. L. Rurup, H. P. Meijer, M. D. Klok, S. Middendorp, R. W. Hendriks, S. T. Pals. 2003. The B cell antigen receptor controls integrin activity through Btk and PLC{gamma}2. J. Exp. Med. 198:1539.[Abstract/Free Full Text]
  50. Lu, T. T., J. G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297:409.[Abstract/Free Full Text]
  51. Baker, N., M. R. Ehrenstein. 2002. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J. Immunol. 169:6686.[Abstract/Free Full Text]
  52. Cascalho, M., J. Wong, M. Wabl. 1997. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J. Immunol. 159:5795.[Abstract]
  53. Keshavarzi, S., C. Rietz, S. Simoes, S. Shih, J. L. Platt, J. Wong, M. Wabl, M. Cascalho. 2003. The possibility of B-cell-dependent T-cell development. Scand. J. Immunol. 57:446.[Medline]
  54. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity 18:675.[Medline]
  55. Witt, C. M., W. J. Won, V. Hurez, C. A. Klug. 2003. Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J. Immunol. 171:2783.[Abstract/Free Full Text]
  56. Karlsson, M. C., R. Guinamard, S. Bolland, M. Sankala, R. M. Steinman, J. V. Ravetch. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198:333.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
G. T. Mantchev, C. S. Cortesao, M. Rebrovich, M. Cascalho, and R. J. Bram
TACI Is Required for Efficient Plasma Cell Differentiation in Response to T-Independent Type 2 Antigens
J. Immunol., August 15, 2007; 179(4): 2282 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. P. O'Connor, L. A. Vogel, W. Zhang, W. Loo, D. Shnider, E. F. Lind, M. Ratliff, R. J. Noelle, and L. D. Erickson
Imprinting the Fate of Antigen-Reactive B Cells through the Affinity of the B Cell Receptor
J. Immunol., December 1, 2006; 177(11): 7723 - 7732.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. Mandik-Nayak, J. Racz, B. P. Sleckman, and P. M. Allen
Autoreactive marginal zone B cells are spontaneously activated but lymph node B cells require T cell help
J. Exp. Med., August 7, 2006; 203(8): 1985 - 1998.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Tsuiji, S. Yurasov, K. Velinzon, S. Thomas, M. C. Nussenzweig, and H. Wardemann
A checkpoint for autoreactivity in human IgM+ memory B cell development
J. Exp. Med., February 21, 2006; 203(2): 393 - 400.
[Abstract] [Full Text] [PDF]

Home page